🔎 Trials Near Me

Utama › Kanser Ginjal (Karsinoma Sel Renal) › Pennsylvania › Pittsburgh

Kajian klinikal Kanser Ginjal (Karsinoma Sel Renal) di Pittsburgh, PA

15 kajian untuk Kanser Ginjal (Karsinoma Sel Renal) sedang mencari peserta di lokasi dalam dan sekitar Pittsburgh (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Mengambil pesertaFasa 1
  • Research Site, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT05536141

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Mengambil pesertaFasa 1
  • UPMC Hillman Cancer Center, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07419841

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Mengambil pesertaFasa 1/2
  • UPMC Cancer Center/Hillman Cancer Center ( Site 5017), Pittsburgh
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07049926

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Mengambil pesertaFasa 1
  • Exelixis Clinical Site #32, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Mengambil pesertaFasa 2
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Passavant Hospital, Pittsburgh
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Mengambil pesertaFasa 2
  • Allegheny General Hospital, Pittsburgh
  • UPMC-Magee Womens Hospital, Pittsburgh
  • UPMC-Saint Margaret, Pittsburgh
  • dan 14 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05327686

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Mengambil pesertaFasa 3
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Passavant Hospital, Pittsburgh
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
  • dan 3 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06661720

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Research Site, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07115043

Autologous Dendritic Cell Vaccine in Kidney Cancer

Mengambil pesertaFasa 2
  • UPMC Department of Urology, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05127824

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • UPMC Hillman Cancer Center, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Mengambil pesertaFasa 1
  • UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Jun 2026 · NCT04777994

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Mengambil pesertaFasa 1/2
  • University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Apr 2026 · NCT06413680

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Mengambil pesertaFasa 2
  • UPMC Hillman Cancer Center, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT07223424

A Study of VET3-TGI in Patients With Solid Tumors

Mengambil pesertaFasa 1
  • UPMC- Hillman Cancer Center, Pittsburgh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Apr 2026 · NCT06444815

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Mengambil pesertaFasa 3
  • UPMC-Saint Margaret, Pittsburgh
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
  • UPMC-Shadyside Hospital, Pittsburgh
  • dan 9 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2025 · NCT04510597

Kajian Kanser Ginjal (Karsinoma Sel Renal) di bandar lain

Kajian lain di Pittsburgh

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.